These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1144483)

  • 1. Behavioral and electrocortical activity in rats after neonatal intraventricular 6-hydroxydropamine administration.
    Nyakas C; Van Delft AM
    Pharmacol Biochem Behav; 1975; 3(2):271-7. PubMed ID: 1144483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neonatal 6-hydroxydopamine treatment on catecholamine levels and behavior during development and adulthood.
    Fobes JL; Olds ME
    Psychopharmacology (Berl); 1981; 73(1):27-30. PubMed ID: 6785785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 6-hydroxydopamine and 6-hydroxydopa on development of behavior.
    Morgan DN; McLean JH; Kostrzewa RM
    Pharmacol Biochem Behav; 1979 Sep; 11(3):309-12. PubMed ID: 504311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central effects of 6-hydroxydopamine.
    De Carolis AS; Ziegler H; Del Basso P; Longo VG
    Physiol Behav; 1971 Nov; 7(5):705-8. PubMed ID: 5170825
    [No Abstract]   [Full Text] [Related]  

  • 8. Neonatal 6-hydroxydopamine attenuates the neural and behavioral effects of enriched rearing in the rat.
    O'Shea L; Saari M; Pappas BA; Ings R; Stange K
    Eur J Pharmacol; 1983 Aug; 92(1-2):43-7. PubMed ID: 6414825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian periodicity and stress responsiveness of the pituitary--adrenal system of rats after central administration of 6-hydroxydopamine.
    Kaplanski J; van Delft AM; Nyakas C; Stoof JC; Smelik PG
    J Endocrinol; 1974 Nov; 63(2):299-310. PubMed ID: 4443690
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adaptation to the behavioral effects of 6-hydroxydopamine].
    Semenova TP; Tret'iak TM; Grishchenko NI; Smirnova GN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1983; 33(1):163-5. PubMed ID: 6404069
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavior-dependent modulation of hippocampal EEG activity by the selective norepinephrine reuptake inhibitor reboxetine in rats.
    Kocsis B; Li S; Hajos M
    Hippocampus; 2007; 17(8):627-33. PubMed ID: 17492692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxydopamine, unspecific centrally acting false neurotransmitter.
    Brus R; Herman ZS; Szkilnik R; Dzikowski A; Opielka L; Bonczek A
    Acta Physiol Pol; 1977; 28(1):13-21. PubMed ID: 868521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the dorsal noradrenergic bundle projections from the locus coeruleus important for neocortical or hippocampal activation?
    Robinson TE; Vanderwolf CH; Pappas BA
    Brain Res; 1977 Dec; 138(1):75-98. PubMed ID: 589470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal 6-hydroxydopamine alters olfactory development.
    Sobrian SK; Cornwell-Jones C
    Behav Biol; 1977 Nov; 21(3):329-40. PubMed ID: 921677
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of 6-hydroxydopamine on habituation of activity in the developing rat pup.
    Shaywitz BA; Gordon JW; Klopper JH; Zelterman DA
    Pharmacol Biochem Behav; 1977 Apr; 6(4):391-6. PubMed ID: 882577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.